Natera (NASDAQ:NTRA) Price Target Raised to $360.00

Дата публикации: 10-08-2026 05:36:48

Natera (NASDAQ:NTRA – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $315.00 to $360.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical research company’s stock. Several other research analysts have also recently issued reports on NTRA. Zacks Research […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Sotera Health (NASDAQ:SHC) Price Target Raised to $18.00	0	12.25	10-08-2026
2	Cencora (NYSE:COR) Price Target Raised to $390.00	0	11.9	10-08-2026
3	TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00	0	13.04	10-08-2026
4	Target (NYSE:TGT) Price Target Raised to $157.00	0	13.85	10-08-2026
5	JFrog (NASDAQ:FROG) Price Target Raised to $115.00	0	14.6	10-08-2026
6	MKS (NASDAQ:MKSI) Price Target Raised to $380.00	0	13.85	10-08-2026
7	Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $146.00	0	14.22	10-08-2026
8	Insight Enterprises (NASDAQ:NSIT) Price Target Raised to $160.00	0	14.65	10-08-2026
9	Centrus Energy (NYSE:LEU) Price Target Raised to $180.00	0	13.43	10-08-2026
10	Replimune Group (NASDAQ:REPL) Price Target Raised to $20.00	0	13.83	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 14.27. Источник: www.americanbankingnews.com.